Immune and stromal cell networks in inflamed joint

The immune and stromal cell networks in the inflamed joint refer to the complex, multicellular interactome within the synovial tissue that drives chronic inflammatory diseases like rheumatoid arthritis (RA). This system is characterized by the pathological crosstalk between infiltrating immune cells, such as T cells, B cells, and macrophages, and resident stromal cells, specifically fibroblast-like synoviocytes (FLS) and endothelial cells. High-resolution studies, notably by the Accelerating Medicines Partnership (AMP), have identified distinct cellular subsets, such as FAP-alpha+ THY1+ sublining fibroblasts and proinflammatory HLA-DR+ CD14+ macrophages, as key drivers of joint destruction (Zhang et al., 2019, Nature). These networks produce a milieu of cytokines, including TNF-alpha, IL-6, and IL-1, which perpetuate leukocyte recruitment and synovial hyperplasia. While the network itself is not a single molecular target, its individual nodes are the focus of major therapies, including TNF inhibitors and JAK inhibitors, which aim to disrupt these inflammatory circuits. Understanding these networks is crucial for developing precision medicine approaches based on synovial pathotypes to predict treatment efficacy (Humby et al., 2019, Annals of the Rheumatic Diseases).

Other names

Synovial cell networksInflammatory synovial microenvironmentJoint stromal-immune interactomeSynovial inflammatory ecosystem

Disruption of multicellular inflammatory circuits by inhibiting specific cytokines, signaling pathways, or cell-surface molecules within the synovial network.